Back
Spero Therapeutics, Inc. 10K Form
Sell
31
SPRO
Spero Therapeutics, Inc.
Last Price:
$2.28
Seasonality Move:
17.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SPRO News And Ratings
See the #1 stock for the next 7 days that we like better than SPRO
SPRO Financial Statistics
Sales & Book Value
| Annual Sales: | $27.4M |
|---|---|
| Cash Flow: | $17.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.47 |
| Price / Book: | 4.85 |
Profitability
| EPS (TTM): | -0.79490 |
|---|---|
| Net Income (TTM): | $-43.8M |
| Gross Margin: | $27.4M |
| Return on Equity: | -107.04% |
| Return on Assets: | -49.85% |
Spero Therapeutics, Inc. Earnings Forecast
Key Spero Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for SPRO is 99.99%.
-
The Selling, General & Administrative Expenses for SPRO have been equal to 86.52% of Gross Profit Margin.
-
The Research & Development expenses have been 353.17% of Revenue.
-
The Net Earning history of SPRO is -250.28% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 8 years.
Spero Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SPRO |
| CUSIP: | 84833T |
| Website: | sperotherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.13 |
|---|---|
| Current Ratio: | 3.83 |
| Quick Ratio: | 3.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 2 |
|---|---|
| Forward P/E Ratio: | 0 |
SPRO Technical Analysis vs Fundamental Analysis
Sell
31
Spero Therapeutics, Inc. (SPRO)
is a Sell
Is Spero Therapeutics, Inc. a Buy or a Sell?
-
Spero Therapeutics, Inc. stock is rated a SellThe current Spero Therapeutics, Inc. [SPRO] share price is $2.28. The Score for SPRO is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.